{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:10Z","timestamp":1761561070683},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T00:00:00Z","timestamp":1151625600000},"content-version":"vor","delay-in-days":4198,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:p>The purpose of this study was to investigate the efficacy and safety of antitachycardia pacing (ATP) in third\u2010generation implantable Cardioverter defibrillators (ICDs) for terminating spontaneously occurring ventricular tachycardias (VTs) in patients with severely depressed left ventricular (LV) function. Ninety\u2010one patients with active ATP were followed for 16 \u00b1 13 months. During this period, 775 VT episodes occurring in 36 patients were treated by ATP. The patients were divided into two groups according to their LV ejection fraction (LVEF): group A with LVEF \u00b1 30% (n = 20), and group B with LVEF \u00b1 30% (n = 16). There were no differences between both groups in age, gender, underlying heart disease, indication for ICD therapy, or drug therapy. The VT rates were comparable (group A: 183 \u00b1 16 beats\/min; group B: 180 \u00b1 21 beats\/min; P = NS). Eighty\u2010three percent of all episodes (n = 332) in group A and 93% of the VTs (n = 443) in group B were ATP terminated (P \u00b1 0.01). Ten percent of VTs in group A were accelerated by ATP into the ventricular fibrillation zone versus 2% in group B (P \u00b1 0.01). The individual termination rate and acceleration rate per patient were comparable in both groups. All VT episodes unresponsive to ATP were converted by backup shocks. The efficacy of first\u2010shock therapy was similar in both groups (group A: 89%; group B: 97%; P = NS). The proportion of patients who needed at least one backup shock for unsuccessful ATP was comparable in both groups (group A: 65%; group B: 56%; P= NS). We conclude that ATP is effective and safe in patients with recurrent VTs and severely depressed LV function, and it can be safely programmed in this group of patients to minimize the use of shock therapy.<\/jats:p>","DOI":"10.1111\/j.1540-8159.1995.tb02492.x","type":"journal-article","created":{"date-parts":[[2006,7,2]],"date-time":"2006-07-02T15:57:30Z","timestamp":1151855850000},"page":"137-141","source":"Crossref","is-referenced-by-count":19,"title":["Safety of Antitachycardia Pacing in Patients with Implantable Cardioverter Defibrillators and Severely Depressed Left Ventricular Function"],"prefix":"10.1111","volume":"18","author":[{"given":"ARMIN","family":"HEISEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00d6RG","family":"NEUZNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EWALD","family":"HIMMRICH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEINZ F.","family":"PITSCHNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREAS","family":"LIEBRICH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JENS","family":"JUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEMI","family":"SEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb01621.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.85.5.1689"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.2.363"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)80232-3"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(10)80260-8"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90343-Y"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90080-9"},{"key":"e_1_2_1_9_2","first-page":"1","article-title":"Impact of depressed ventricular function on effectiveness of antitachycardia pacing for sustained ventricular tachycardia","volume":"88","author":"Packer DL","year":"1993","journal-title":"Circulation"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.1995.tb02492.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.1995.tb02492.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:30:44Z","timestamp":1698366644000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.1995.tb02492.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1540-8159.1995.tb02492.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.1995.tb02492.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}